Clinical trial
High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients…
NCT00040482 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00040482 |
|---|---|
| Title | High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis |
| Official title | Intensive Immunosuppression Followed by Rescue With CD34 Selected, T Cell Depleted, Leukopheresis Products in Patients With Multiple Sclerosis |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug, Procedure |
| Interventions | Cyclophosphamide, ATG, MESNA, Radiation therapy |
| Enrollment | 10 |
| Start date | Apr 1, 1999 |
| Completion | Aug 1, 2005 |
| First posted | Jun 28, 2002 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: